Non-Alcoholic Steatohepatitis Treatment Market Size, Share And Global Forecast 2023-2032

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Non-Alcoholic Steatohepatitis Treatment Global Market Report 2023 identifies an increased prevalence of insulin resistance as the major driver for the non-alcoholic steatohepatitis treatment market's growth in the forecast period. Insulin resistance occurs when muscles, fat, and liver cells do not respond adequately to insulin and cannot easily absorb glucose from the blood, causing high blood sugar. These are linked to an unhealthy lifestyle, excessive sugar consumption, and genetics. The use of insulin resistance has multiplied due to increased diabetes and other liver-related issues, which are treated with non-alcoholic steatohepatitis treatment.

The global non-alcoholic steatohepatitis treatment market size is expected to grow from $1.36 billion in 2022 to $1.89 billion in 2023 at a compound annual growth rate (CAGR) of 38.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the non-alcoholic steatohepatitis treatment market is expected to reach $6.87 billion in 2027 at a CAGR of 38.1%.

Download Free Sample Of Non-Alcoholic Steatohepatitis Treatment Market Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=8595&type=smp

Major competitors in the non-alcoholic steatohepatitis treatment market are AstraZeneca Plc., Tobira Therapeutics Inc., Galmed Pharmaceuticals, Genfit SA, Zydus Cadila.

A key trend in the non-alcoholic steatohepatitis treatment market includes the development of the non-alcoholic steatohepatitis (NASH) drug. Many companies are investing in developing innovative drugs for the treatment of liver diseases with reduced side effects of the drugs. For instance, in May 2022, Pfizer Inc., an American pharmaceutical and biotechnology company, received a grant from U.S. Food and Drug Administration (FDA) for fast-track designation to facilitate the development of the non-alcoholic steatohepatitis (NASH) drug, namely ervogastat and clesacostat. Fast Track is a process designed to Pfizer's investigational combination therapy for the treatment of non-alcoholic steatohepatitis (NASH) with liver fibrosis named as; ervogastat (PF-06865571, a diacylglycerol O-acyltransferase 2 inhibitor, or DGAT2i) and clesacostat (PF-05221304, an acetyl-CoA carboxylase inhibitor, or ACCi).

Read More On The Global Non-Alcoholic Steatohepatitis Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/report/non-alcoholic-steatohepatitis-treatment-global-market-report

The non-alcoholic steatohepatitis treatment market is segmented -
•By Drug Type: Vitamin E And Pioglitazone, Ocaliva, Elafibranor, Selonsertib And cenicriviroc, Obeticholic Acid, Other Drugs Types
•By Test Type: Blood Tests, Liver Biopsy, Imaging Procedures
•By End User: Hospital Pharmacies, Retail And Specialty Pharmacies, Other End Users
•By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the non-alcoholic steatohepatitis treatment market.

The Business Research Company's "Global Non-Alcoholic Steatohepatitis Treatment Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Non-Alcoholic Steatohepatitis Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8595

The Table Of Content For The Non-Alcoholic Steatohepatitis Treatment Market Include:
1. Executive Summary
2. Non-Alcoholic Steatohepatitis Treatment Market Characteristics
4. Non-Alcoholic Steatohepatitis Treatment Market - Macro Economic Scenario
5. Non-Alcoholic Steatohepatitis Treatment Market Size And Growth
……
26. Africa Non-Alcoholic Steatohepatitis Treatment Market
27. Non-Alcoholic Steatohepatitis Treatment Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Non-Alcoholic Steatohepatitis Treatment Market
29. Non-Alcoholic Steatohepatitis Treatment Market Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.